A 28-year-old primigravida delivers a healthy 3.2 kg male infant vaginally after an 8-hour labor. The third stage of labor is managed actively with oxytocin 10 IU IM and controlled cord traction. At 15 minutes postpartum, the uterus is soft and boggy on palpation. Vaginal bleeding is brisk, with an estimated blood loss of 800 mL. Vital signs: BP 100/62 mmHg, HR 110/min, RR 20/min. Hemoglobin is 9.2 g/dL (pre-delivery: 11.8 g/dL). What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis This patient has **primary postpartum hemorrhage (PPH)** due to **uterine atony** — the most common cause, accounting for 70% of PPH cases. ### Why Uterine Atony? - Soft, boggy uterus on palpation is pathognomonic - Brisk vaginal bleeding in the immediate third stage - Hemoglobin drop of 2.6 g/dL confirms significant blood loss - Active management with oxytocin was already given but inadequate ## Management Algorithm for Uterine Atony ```mermaid flowchart TD A[Uterine Atony Diagnosed]:::outcome --> B[Uterus soft/boggy + excessive bleeding]:::outcome B --> C[Oxytocin already given]:::action C --> D{Bleeding controlled?}:::decision D -->|No| E[Ergot alkaloid IM/IV]:::action D -->|Yes| F[Continue oxytocin infusion]:::action E --> G{Still bleeding?}:::decision G -->|No| H[Observe, IV fluids, transfuse if Hb <7]:::action G -->|Yes| I[Prostaglandins or surgical intervention]:::urgent ``` ## Why Ergot Alkaloid (Methylergonovine) Is Correct **Key Point:** Ergot alkaloids are the second-line uterotonic after oxytocin fails to control atony. | Agent | Mechanism | Onset | Duration | Contraindication | |-------|-----------|-------|----------|------------------| | Oxytocin | V1-receptor agonist, rhythmic contractions | 1–2 min | 10–20 min | None (safe) | | Methylergonovine | α-adrenergic agonist, sustained tetanic contraction | 2–5 min | 3–4 hours | Hypertension, preeclampsia, CAD | | Carboprost (15-methyl PGF~2α~) | Prostaglandin F receptor, strong contractions | 1–3 min | 1–3 hours | Asthma, bronchospasm | | Misoprostol (PGE~1~) | Prostaglandin E receptor | 10–15 min | 2–3 hours | Diarrhea, fever | **High-Yield:** After oxytocin, methylergonovine 0.2 mg IM (or 0.2 mg IV over 1 minute if IV access available) is the standard second-line agent for uterine atony. **Clinical Pearl:** The patient's BP is 100/62 — not hypertensive — so ergot alkaloid is safe. In preeclampsia or hypertension, avoid ergots and use prostaglandins instead. ## Why Blood Transfusion Is NOT the Next Step - Hemoglobin 9.2 g/dL is above the transfusion threshold of 7 g/dL in a hemodynamically stable patient - The bleeding is ongoing due to atony, not anemia — treat the cause first - Transfusion is indicated only if bleeding persists after uterotonic therapy or Hb drops further ## Why Uterine Artery Embolization Is Premature - This is a tertiary intervention reserved for massive hemorrhage refractory to uterotonics and surgical measures - Not indicated at this stage of management ## Why Manual Exploration Is Not First-Line - Manual exploration is performed to exclude retained products of conception (RPOC), placental fragments, or uterine rupture - In pure uterine atony with an intact placenta (delivered), exploration is not indicated - It is considered if RPOC is suspected or bleeding persists despite uterotonics [cite:Williams Obstetrics 26e Ch 41]